SCHEMBL1029486

SCHEMBL1029486

CC(C)(F)C(C)(F)OC(C)(F)C(C)(C)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679836 0.75 ALDH1A1 (0.33) ALDH1A1
SCHEMBL27416510 0.73
SCHEMBL11501540 0.69 TSHR (0.33)
SCHEMBL890401 0.69
SCHEMBL580213 0.67 LMNA (0.33)
SCHEMBL15468771 0.67 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1683998 0.67
SCHEMBL14456621 0.66
SCHEMBL22471718 0.65 LMNA (0.38)
SCHEMBL422693 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117840009-A Method for forming coating film of photocurable fluoropolyether elastomer composition 信越化学工业株式会社 2024-04-09 CN disclosed
CN-113165012-B Method for forming coating film of photocurable fluoropolyether elastomer composition 信越化学工业株式会社 2024-01-30 CN disclosed
US-11817310-B2 Bevel portion treatment agent composition and method of manufacturing wafer CENTRAL GLASS COMPANY, LIMITED (JP) 2023-11-14 US disclosed
US-20220020582-A1 BEVEL PORTION TREATMENT AGENT COMPOSITION AND METHOD OF MANUFACTURING WAFER CENTRAL GLASS COMPANY, LIMITED (JP) 2022-01-20 US disclosed
US-20210171810-A1 Two Step Adhesive System HENKEL AG & CO. KGAA (DE) 2021-06-10 US disclosed
WO-2020195454-A1 METHOD FOR DEHYDRATING ORGANIC SOLVENT AND METHOD FOR PURIFYING ORGANIC SOLVENT 日本ゼオン株式会社 2020-10-01 WO disclosed
WO-2020035580-A1 TWO STEP ADHESIVE SYSTEMS Henkel IP & Holding GmbH (DE) 2020-02-20 WO disclosed
US-8258243-B2 Grafted silicone polymer and products made therewith 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-09-04 US disclosed
EP-2144954-B1 GRAFTED SILICONE POLYMER AND PRODUCTS MADE THEREWITH 3M INNOVATIVE PROPERTIES CO (US) 2011-01-19 EP disclosed
US-20100130693-A1 GRAFTED SILICONE POLYMER AND PRODUCTS MADE THEREWITH 3M INNOVATIVE PROPERTIES COMPANY 2010-05-27 US disclosed
EP-2144954-A1 GRAFTED SILICONE POLYMER AND PRODUCTS MADE THEREWITH 3M Innovative Properties Company (US) 2010-01-20 EP disclosed
WO-2008134428-A1 GRAFTED SILICONE POLYMER AND PRODUCTS MADE THEREWITH 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020582-A1 BEVEL PORTION TREATMENT AGENT COMPOSITION AND METHOD OF MANUFACTURING WAFER SGMS1, SGMS2, SEM1 ALDH1A1 1047/4885
US-11817310-B2 Bevel portion treatment agent composition and method of manufacturing wafer SGMS1, SGMS2, SEM1 ALDH1A1 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.